+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cellular Health Screening Market Size, Share & Industry Trends Analysis Report by Sample Type (Blood, Saliva, Serum, and Urine), Collection Site, Test Type (Single Test Panels and Multi-test Panels), Regional Outlook and Forecast, 2022-2028

  • PDF Icon

    Report

  • 250 Pages
  • October 2022
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5694687
The Global Cellular Health Screening Market size is expected to reach $4.3 billion by 2028, rising at a market growth of 9.0% CAGR during the forecast period.

Cellular health screening is a cutting-edge innovation used to quickly assess cellular health. The screening illustrates how the cells function in relation to the body. The screening aids in determining conditions such as cellular toxicity, fat mass, cellular capabilities, dynamic tissue mass, and extracellular and intracellular liquid levels. The fundamental components of life are cells, which come together to form organs.



Bio-energy is produced by healthy cells, which eventually results in normal health. Since it can accurately assess a person's level of health and provide details about cellular health and performance, cellular health screening has grown in importance in recent years. This screening method helps doctors and other healthcare professionals better understand how cells in the body behave and function.

A key component of precision medicine is the easy monitoring and control of treatment options made possible by cellular health screening. Additionally, it provides information on cellular activity and muscle mass, which has increased its adoption in routine health examinations.

When a person does not exhibit any symptoms of a condition, a screening test is performed to look for probable health issues or diseases. The objective is early identification, lifestyle modifications, or surveillance to lower the likelihood of disease or to identify it soon enough to receive the best possible care.

COVID-19 Impact Analysis

As a consequence of the COVID-19 pandemic, businesses that provide cellular health screening products and services saw a decline in their revenues and base testing volume. Along with the government directives connected to the pandemic, the supply chain was hampered by transportation constraints and prohibitions on the export and import of commodities and raw materials. Consequently, many companies expanded their product offerings to incorporate COVID-19 antibody and molecular testing in response to the fall in demand brought on by the interruption of the supply chain, which could balance the decrease in a base testing capacity.

Market Growth Factors

Rise in the global geriatric population

Cellular health screening is essential because aging and poor lifestyles are the main sources of dietary imbalances in the human body. Commercially available supplements are available to boost nutritional levels. The fundamental cause of oxidative stress, fatigue, stress, as well as other symptoms is a decline in cell health. However, a lack of necessary nutrients will gradually limit cells' ability to operate normally, which will lead to sickness. The levels of NAD+, an enzyme needed by every cell for optimal operation, decrease by half between the ages of 40 and 60. Additionally, a shorter telomere can result in a number of side effects, including liver illness, lung fibrosis, and bone marrow failure.

Expanded Use of Personalized Medicines

The growth of cellular health screening is attributed to its expanding use in personalized medicine. The International Consortium for Personalized Medicine (ICPerMed) considers that technology innovation, along with the advancement of the biomedical, social, and economic sciences, is what propels PM. Therefore, a significant investment in innovation and research is necessary for its successful execution. Personalized medicine generally consists of two components. A biological, medication or any other form of therapeutic intervention is the first, and a diagnostic test is the second.

Marketing Restraining Factor:

High cost of cellular screening kits and lack of specialized workers

The cost of cellular health screening kits can be high, which sustains their usage by the majority beyond a point. Another aspect that has an impact on the growth of Cellular Health Screening is the fragility of samples and the instability of kits. Both of these reduce the responsiveness of the program and the efficiency of the process. Their high maintenance has made them ineligible to be used in every case, especially in cases where the sample collection is limited. Additionally, the rising sample transportation challenges and unfavorable reimbursement policies decline the preference for cellular health screening kits.



Sample Type Outlook

On the basis of sample type, the cellular health screening market is divided into blood, saliva, serum, and urine. The urine sample segment witnessed a significant revenue share in the cellular health screening market in 2021. Since urine collection does not require technical people and is non-invasive, it is patient-friendly and significantly quicker. Additionally, studies have shown that urine screening may accurately assess oxidative stress. For instance, researchers from Japan demonstrated in a study article that smoking and oxidative stress are linked to the level of pteridine compounds in urine. As a result, the market for urine sample type screening is predicted to rise as a result of the growing screening of oxidative stress in the body.

Collection Site Outlook

Based on collection site, the cellular health screening market is segmented into home, office, hospital, and diagnostic labs. The home segment procured a promising revenue share in the cellular health screening market in 2021. This is explained by rising health consciousness and the widespread use of self-sampling in important marketplaces. Self-sampling has become popular because it is simple to use and doesn't call for specialized equipment or qualified personnel. Additionally, the COVID-19 pandemic resulted in a widespread inclination for home collections because of the restrictions on movement, and this inclination will persist for years to come.

Test Type Outlook

Based on test type, the cellular health screening market is categorized into single test panels and multi-test panels. The single test panels dominated the cellular health screening market with the highest revenue share in 2021. Products for single-panel tests offer affordable, precise, and quick screening for a specific, particular class of disease. Simple single panel tests use a sample to detect biomarkers that could be precursors for the disease. Such diagnostic tests are appropriate for both business and personal use, whether conducted in the workplace or at home. Within minutes, tests produce qualitative data that are visible and easy to comprehend.

Oxidative Stress Tests Outlook

The single test panels segment is further divided into telomere tests, oxidative stress tests, inflammation tests, and heavy metals tests. The oxidative stress tests acquired the largest revenue share in the cellular health screening market in 2021. Cancer, respiratory conditions, diabetes, cardiovascular conditions, and other illnesses are helped by these tests. Oxidative stress is a result of an imbalance between the generation of free radicals (ROS, or reactive oxygen species), and the body's already-existing antioxidant capacity (AC). An enhancement in antioxidant capacity frequently results in a decrease in ROS generation, whilst a rise in the AC may result in a drop in ROS values.

Regional Outlook

On the basis of region, the cellular health screening market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North American region recorded the largest revenue share in the cellular health screening market in 2021. Healthy Life Expectancy (HALE), which measures how long people live in good health, rising healthcare costs, and government support for preventative care are some of the major contributing elements in this area. Additionally, the existence of significant important players, the simplicity with which new technologies are adopted, and the prevalence of chronic and infectious diseases among the populace all contribute to regional growth.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics Incorporated, OPKO Health, Inc., Laboratory Corporation of America Holdings, Genova Diagnostics, Telomere Diagnostics, Inc., Life Length, S.L., Repeat Diagnostics, Inc., SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.), Cell Science Systems Corp. and Segterra, Inc.

Scope of the Study

By Sample Type

  • Blood
  • Saliva
  • Serum
  • Urine

By Collection Site

  • Hospital
  • Diagnostic Labs
  • Home
  • Office

By Test Type

  • Single Test Panels
    • Oxidative Stress Tests
    • Inflammation Tests
    • Telomere Tests
    • Heavy Metals Tests
  • Multi-test Panels

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:


Companies Profiled

  • Quest Diagnostics Incorporated
  • OPKO Health, Inc.
  • Laboratory Corporation of America Holdings
  • Genova Diagnostics
  • Telomere Diagnostics, Inc.
  • Life Length, S.L.
  • Repeat Diagnostics, Inc.
  • SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
  • Cell Science Systems Corp.
  • Segterra, Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Frequently Asked Questions about the Global Cellular Health Screening Market

What is the estimated value of the Global Cellular Health Screening Market?

The Global Cellular Health Screening Market was estimated to be valued at $2401 Million in 2021.

What is the growth rate of the Global Cellular Health Screening Market?

The growth rate of the Global Cellular Health Screening Market is 9.0%, with an estimated value of $4269 Million by 2028.

What is the forecasted size of the Global Cellular Health Screening Market?

The Global Cellular Health Screening Market is estimated to be worth $4269 Million by 2028.

Who are the key companies in the Global Cellular Health Screening Market?

Key companies in the Global Cellular Health Screening Market include Quest Diagnostics Incorporated, OPKO Health, Inc., Laboratory Corporation of America Holdings, Genova Diagnostics, Telomere Diagnostics, Inc., Life Length, S.L., Repeat Diagnostics, Inc., SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.), Cell Science Systems Corp. and Segterra, Inc..

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Cellular Health Screening Market, by Sample Type
1.4.2 Global Cellular Health Screening Market, by Collection Site
1.4.3 Global Cellular Health Screening Market, by Test Type
1.4.4 Global Cellular Health Screening Market, by Geography
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Cellular Health Screening Market by Sample Type
3.1 Global Blood Market by Region
3.2 Global Saliva Market by Region
3.3 Global Serum Market by Region
3.4 Global Urine Market by Region
Chapter 4. Global Cellular Health Screening Market by Collection Site
4.1 Global Hospital Market by Region
4.2 Global Diagnostic Labs Market by Region
4.3 Global Home Market by Region
4.4 Global Office Market by Region
Chapter 5. Global Cellular Health Screening Market by Test Type
5.1 Global Single Test Panels Market by Region
5.2 Global Cellular Health Screening Market by Single Test Panels Type
5.2.1 Global Oxidative Stress Tests Market by Region
5.2.2 Global Inflammation Tests Market by Region
5.2.3 Global Telomere Tests Market by Region
5.2.4 Global Heavy Metals Tests Market by Region
5.3 Global Multi-test Panels Market by Region
Chapter 6. Global Cellular Health Screening Market by Region
6.1 North America Cellular Health Screening Market
6.1.1 North America Cellular Health Screening Market by Sample Type
6.1.1.1 North America Blood Market by Country
6.1.1.2 North America Saliva Market by Country
6.1.1.3 North America Serum Market by Country
6.1.1.4 North America Urine Market by Country
6.1.2 North America Cellular Health Screening Market by Collection Site
6.1.2.1 North America Hospital Market by Country
6.1.2.2 North America Diagnostic Labs Market by Country
6.1.2.3 North America Home Market by Country
6.1.2.4 North America Office Market by Country
6.1.3 North America Cellular Health Screening Market by Test Type
6.1.3.1 North America Single Test Panels Market by Country
6.1.3.2 North America Cellular Health Screening Market by Single Test Panels Type
6.1.3.2.1 North America Oxidative Stress Tests Market by Country
6.1.3.2.2 North America Inflammation Tests Market by Country
6.1.3.2.3 North America Telomere Tests Market by Country
6.1.3.2.4 North America Heavy Metals Tests Market by Country
6.1.3.3 North America Multi-test Panels Market by Country
6.1.4 North America Cellular Health Screening Market by Country
6.1.4.1 US Cellular Health Screening Market
6.1.4.1.1 US Cellular Health Screening Market by Sample Type
6.1.4.1.2 US Cellular Health Screening Market by Collection Site
6.1.4.1.3 US Cellular Health Screening Market by Test Type
6.1.4.2 Canada Cellular Health Screening Market
6.1.4.2.1 Canada Cellular Health Screening Market by Sample Type
6.1.4.2.2 Canada Cellular Health Screening Market by Collection Site
6.1.4.2.3 Canada Cellular Health Screening Market by Test Type
6.1.4.3 Mexico Cellular Health Screening Market
6.1.4.3.1 Mexico Cellular Health Screening Market by Sample Type
6.1.4.3.2 Mexico Cellular Health Screening Market by Collection Site
6.1.4.3.3 Mexico Cellular Health Screening Market by Test Type
6.1.4.4 Rest of North America Cellular Health Screening Market
6.1.4.4.1 Rest of North America Cellular Health Screening Market by Sample Type
6.1.4.4.2 Rest of North America Cellular Health Screening Market by Collection Site
6.1.4.4.3 Rest of North America Cellular Health Screening Market by Test Type
6.2 Europe Cellular Health Screening Market
6.2.1 Europe Cellular Health Screening Market by Sample Type
6.2.1.1 Europe Blood Market by Country
6.2.1.2 Europe Saliva Market by Country
6.2.1.3 Europe Serum Market by Country
6.2.1.4 Europe Urine Market by Country
6.2.2 Europe Cellular Health Screening Market by Collection Site
6.2.2.1 Europe Hospital Market by Country
6.2.2.2 Europe Diagnostic Labs Market by Country
6.2.2.3 Europe Home Market by Country
6.2.2.4 Europe Office Market by Country
6.2.3 Europe Cellular Health Screening Market by Test Type
6.2.3.1 Europe Single Test Panels Market by Country
6.2.3.2 Europe Cellular Health Screening Market by Single Test Panels Type
6.2.3.2.1 Europe Oxidative Stress Tests Market by Country
6.2.3.2.2 Europe Inflammation Tests Market by Country
6.2.3.2.3 Europe Telomere Tests Market by Country
6.2.3.2.4 Europe Heavy Metals Tests Market by Country
6.2.3.3 Europe Multi-test Panels Market by Country
6.2.4 Europe Cellular Health Screening Market by Country
6.2.4.1 Germany Cellular Health Screening Market
6.2.4.1.1 Germany Cellular Health Screening Market by Sample Type
6.2.4.1.2 Germany Cellular Health Screening Market by Collection Site
6.2.4.1.3 Germany Cellular Health Screening Market by Test Type
6.2.4.2 UK Cellular Health Screening Market
6.2.4.2.1 UK Cellular Health Screening Market by Sample Type
6.2.4.2.2 UK Cellular Health Screening Market by Collection Site
6.2.4.2.3 UK Cellular Health Screening Market by Test Type
6.2.4.3 France Cellular Health Screening Market
6.2.4.3.1 France Cellular Health Screening Market by Sample Type
6.2.4.3.2 France Cellular Health Screening Market by Collection Site
6.2.4.3.3 France Cellular Health Screening Market by Test Type
6.2.4.4 Russia Cellular Health Screening Market
6.2.4.4.1 Russia Cellular Health Screening Market by Sample Type
6.2.4.4.2 Russia Cellular Health Screening Market by Collection Site
6.2.4.4.3 Russia Cellular Health Screening Market by Test Type
6.2.4.5 Spain Cellular Health Screening Market
6.2.4.5.1 Spain Cellular Health Screening Market by Sample Type
6.2.4.5.2 Spain Cellular Health Screening Market by Collection Site
6.2.4.5.3 Spain Cellular Health Screening Market by Test Type
6.2.4.6 Italy Cellular Health Screening Market
6.2.4.6.1 Italy Cellular Health Screening Market by Sample Type
6.2.4.6.2 Italy Cellular Health Screening Market by Collection Site
6.2.4.6.3 Italy Cellular Health Screening Market by Test Type
6.2.4.7 Rest of Europe Cellular Health Screening Market
6.2.4.7.1 Rest of Europe Cellular Health Screening Market by Sample Type
6.2.4.7.2 Rest of Europe Cellular Health Screening Market by Collection Site
6.2.4.7.3 Rest of Europe Cellular Health Screening Market by Test Type
6.3 Asia Pacific Cellular Health Screening Market
6.3.1 Asia Pacific Cellular Health Screening Market by Sample Type
6.3.1.1 Asia Pacific Blood Market by Country
6.3.1.2 Asia Pacific Saliva Market by Country
6.3.1.3 Asia Pacific Serum Market by Country
6.3.1.4 Asia Pacific Urine Market by Country
6.3.2 Asia Pacific Cellular Health Screening Market by Collection Site
6.3.2.1 Asia Pacific Hospital Market by Country
6.3.2.2 Asia Pacific Diagnostic Labs Market by Country
6.3.2.3 Asia Pacific Home Market by Country
6.3.2.4 Asia Pacific Office Market by Country
6.3.3 Asia Pacific Cellular Health Screening Market by Test Type
6.3.3.1 Asia Pacific Single Test Panels Market by Country
6.3.3.2 Asia Pacific Cellular Health Screening Market by Single Test Panels Type
6.3.3.2.1 Asia Pacific Oxidative Stress Tests Market by Country
6.3.3.2.2 Asia Pacific Inflammation Tests Market by Country
6.3.3.2.3 Asia Pacific Telomere Tests Market by Country
6.3.3.2.4 Asia Pacific Heavy Metals Tests Market by Country
6.3.3.3 Asia Pacific Multi-test Panels Market by Country
6.3.4 Asia Pacific Cellular Health Screening Market by Country
6.3.4.1 China Cellular Health Screening Market
6.3.4.1.1 China Cellular Health Screening Market by Sample Type
6.3.4.1.2 China Cellular Health Screening Market by Collection Site
6.3.4.1.3 China Cellular Health Screening Market by Test Type
6.3.4.2 Japan Cellular Health Screening Market
6.3.4.2.1 Japan Cellular Health Screening Market by Sample Type
6.3.4.2.2 Japan Cellular Health Screening Market by Collection Site
6.3.4.2.3 Japan Cellular Health Screening Market by Test Type
6.3.4.3 India Cellular Health Screening Market
6.3.4.3.1 India Cellular Health Screening Market by Sample Type
6.3.4.3.2 India Cellular Health Screening Market by Collection Site
6.3.4.3.3 India Cellular Health Screening Market by Test Type
6.3.4.4 Australia Cellular Health Screening Market
6.3.4.4.1 Australia Cellular Health Screening Market by Sample Type
6.3.4.4.2 Australia Cellular Health Screening Market by Collection Site
6.3.4.4.3 Australia Cellular Health Screening Market by Test Type
6.3.4.5 South Korea Cellular Health Screening Market
6.3.4.5.1 South Korea Cellular Health Screening Market by Sample Type
6.3.4.5.2 South Korea Cellular Health Screening Market by Collection Site
6.3.4.5.3 South Korea Cellular Health Screening Market by Test Type
6.3.4.6 Malaysia Cellular Health Screening Market
6.3.4.6.1 Malaysia Cellular Health Screening Market by Sample Type
6.3.4.6.2 Malaysia Cellular Health Screening Market by Collection Site
6.3.4.6.3 Malaysia Cellular Health Screening Market by Test Type
6.3.4.7 Rest of Asia Pacific Cellular Health Screening Market
6.3.4.7.1 Rest of Asia Pacific Cellular Health Screening Market by Sample Type
6.3.4.7.2 Rest of Asia Pacific Cellular Health Screening Market by Collection Site
6.3.4.7.3 Rest of Asia Pacific Cellular Health Screening Market by Test Type
6.4 LAMEA Cellular Health Screening Market
6.4.1 LAMEA Cellular Health Screening Market by Sample Type
6.4.1.1 LAMEA Blood Market by Country
6.4.1.2 LAMEA Saliva Market by Country
6.4.1.3 LAMEA Serum Market by Country
6.4.1.4 LAMEA Urine Market by Country
6.4.2 LAMEA Cellular Health Screening Market by Collection Site
6.4.2.1 LAMEA Hospital Market by Country
6.4.2.2 LAMEA Diagnostic Labs Market by Country
6.4.2.3 LAMEA Home Market by Country
6.4.2.4 LAMEA Office Market by Country
6.4.3 LAMEA Cellular Health Screening Market by Test Type
6.4.3.1 LAMEA Single Test Panels Market by Country
6.4.3.2 LAMEA Cellular Health Screening Market by Single Test Panels Type
6.4.3.2.1 LAMEA Oxidative Stress Tests Market by Country
6.4.3.2.2 LAMEA Inflammation Tests Market by Country
6.4.3.2.3 LAMEA Telomere Tests Market by Country
6.4.3.2.4 LAMEA Heavy Metals Tests Market by Country
6.4.3.3 LAMEA Multi-test Panels Market by Country
6.4.4 LAMEA Cellular Health Screening Market by Country
6.4.4.1 Brazil Cellular Health Screening Market
6.4.4.1.1 Brazil Cellular Health Screening Market by Sample Type
6.4.4.1.2 Brazil Cellular Health Screening Market by Collection Site
6.4.4.1.3 Brazil Cellular Health Screening Market by Test Type
6.4.4.2 Argentina Cellular Health Screening Market
6.4.4.2.1 Argentina Cellular Health Screening Market by Sample Type
6.4.4.2.2 Argentina Cellular Health Screening Market by Collection Site
6.4.4.2.3 Argentina Cellular Health Screening Market by Test Type
6.4.4.3 UAE Cellular Health Screening Market
6.4.4.3.1 UAE Cellular Health Screening Market by Sample Type
6.4.4.3.2 UAE Cellular Health Screening Market by Collection Site
6.4.4.3.3 UAE Cellular Health Screening Market by Test Type
6.4.4.4 Saudi Arabia Cellular Health Screening Market
6.4.4.4.1 Saudi Arabia Cellular Health Screening Market by Sample Type
6.4.4.4.2 Saudi Arabia Cellular Health Screening Market by Collection Site
6.4.4.4.3 Saudi Arabia Cellular Health Screening Market by Test Type
6.4.4.5 South Africa Cellular Health Screening Market
6.4.4.5.1 South Africa Cellular Health Screening Market by Sample Type
6.4.4.5.2 South Africa Cellular Health Screening Market by Collection Site
6.4.4.5.3 South Africa Cellular Health Screening Market by Test Type
6.4.4.6 Nigeria Cellular Health Screening Market
6.4.4.6.1 Nigeria Cellular Health Screening Market by Sample Type
6.4.4.6.2 Nigeria Cellular Health Screening Market by Collection Site
6.4.4.6.3 Nigeria Cellular Health Screening Market by Test Type
6.4.4.7 Rest of LAMEA Cellular Health Screening Market
6.4.4.7.1 Rest of LAMEA Cellular Health Screening Market by Sample Type
6.4.4.7.2 Rest of LAMEA Cellular Health Screening Market by Collection Site
6.4.4.7.3 Rest of LAMEA Cellular Health Screening Market by Test Type
Chapter 7. Company Profiles
7.1 Quest Diagnostics Incorporated
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Recent Strategies and Developments
7.1.4.1 Partnerships, Collaborations, and Agreements
7.1.4.2 Product Launches and Product Expansions
7.2 OPKO Health, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.3 Laboratory Corporation of America Holdings
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.4 Genova Diagnostics
7.4.1 Company Overview
7.4.2 Recent Strategies and Developments
7.4.2.1 Partnerships, Collaborations, and Agreements
7.5 Telomere Diagnostics, Inc.
7.5.1 Company Overview
7.6 Life Length, S.L.
7.6.1 Company Overview
7.7 Repeat Diagnostics, Inc.
7.7.1 Company Overview
7.8 SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
7.8.1 Company Overview
7.9 Cell Science Systems Corp.
7.9.1 Company Overview
7.10. Segterra, Inc. (INSIDETRACKER)
7.10.1 Company Overview

Companies Mentioned

  • Quest Diagnostics Incorporated
  • OPKO Health, Inc.
  • Laboratory Corporation of America Holdings
  • Genova Diagnostics
  • Telomere Diagnostics, Inc.
  • Life Length, S.L.
  • Repeat Diagnostics, Inc.
  • SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
  • Cell Science Systems Corp.
  • Segterra, Inc.

Methodology

Loading
LOADING...